Jim Geraghty is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chairman at OMass Therapeutics and Board Chair at Pieris Pharmaceuticals and Orchard Therapeutics, Jim also holds director positions at Fulcrum Therapeutics and Voyager Therapeutics, Inc. Previous roles include Senior Vice President at both sanofi-aventis and Genzyme, and Manager at Bain & Company. Jim's educational background includes a Doctor of Law (J.D.) from Yale Law School, a Master of Science in Psychology from the University of Pennsylvania, and a Bachelor of Arts in English Literature from Georgetown University.